Amber Dahlin
Brigham and Women's Hospital(US)Harvard University(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Metabolomics and Mass Spectrometry Studies, IL-33, ST2, and ILC Pathways, Gut microbiota and health, Chronic Obstructive Pulmonary Disease (COPD) Research
Most-Cited Works
- → Membrane transporters in drug development(2010)3,297 cited
- → A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis(2018)199 cited
- → The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin(2012)185 cited
- → Asthma Metabolomics and the Potential for Integrative Omics in Research and the Clinic(2016)170 cited
- → Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB(2002)155 cited
- → Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma(2018)132 cited
- → Expression and immunolocalization of the plasma membrane monoamine transporter in the brain(2007)128 cited
- → Cutting Edge: CD83 Regulates the Development of Cellular Immunity(2002)120 cited
- → Placental Drug Transporters(2004)115 cited
- → Expression Profiling of the Solute Carrier Gene Family in the Mouse Brain(2009)103 cited